Friday, December 01, 2006

Researcher, Pro-Life Advocates React to Abortion Drug-Breast Cancer Study

A leading biochemist who has published internationally-respected studies on breast cancer and a top pro-life organization both reacted to a study released Thursday showing the RU 486 abortion drug helped suppress the breast cancer gene in mice. They agreed the drug will not likely benefit humans. The University of California study showed that the RU 486 abortion drug works to suppress the progesterone hormone that triggers the breast cancer gene to produce cancerous tumors. But Dr. Joel Brind, a Yale-educated endocrinologist who teaches biology at Baruch College in New York, told LifeNews.com he doesn't think the drug will offer any benefit to women. "There is reason to believe that RU 486 as an anti-progestin might suppress growth of breast cancer in an experimental system in rodents, but RU 486 also neutralizes the essential hormone cortisol which mice do not make," Brind said. "Therefore, there is good reason to believe that such a drug would not be an effective anti-cancer drug in people," he told LifeNews.com. --Click the title of this post to read the full article from its source--

Labels: , , , ,

0 Comments:

Post a Comment

<< Home

/* WebRing Code */